Brasília – In response to recent tariff surcharges imposed by the Trump administration, Brazil is actively pursuing strategic partnerships with the United Kingdom, China and India in the health sector. The Brazilian government sees this as a move to diversify supply chains for medicines, vaccines and health technologies, reducing dependency on the U.S. market and mitigating the impact of protectionist measures.

Brazilian health and trade officials intend to explore shared production, technology transfer, and joint regulatory pathways with these countries, hoping to streamline imports and enhance resilience in the domestic pharmaceutical ecosystem. The strategy may also bolster Brazil’s negotiating power in global health diplomacy, especially amid growing geopolitical tensions over access to medical goods.

Source: O Globo

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com